Effect [qlco]    
interferon therapy [topp]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Mortalities [qnco]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Retrospective Cohort Study [resa]    
patient [podg]    
Effect [qlco]    
Long-term [tmco]    
Clinical [qlco]    
Outcome [ftcn]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
This [euka]    
studies [mnob]    
include [ftcn]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Receive [qlco]    
interferon therapy [topp]    
Alpha [inpr]    
Group [idcn]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Not [ftcn]    
Receive [qlco]    
Control Group [grup]    
patient [podg]    
Group [idcn]    
Classified [clas]    
Following [tmco]    
Three [qnco]    
Group [idcn]    
base [ftcn]    
Response [orga]    
Serum [bdsu]    
Level [qlco]    
*^patient [podg]    
Complete [qlco]    
Therapies [ftcn]    
Protocol [inpr]    
sustain [ftcn]    
Transient [popg]    
Non [ftcn]    
Age [orga]    
Sex [orgf]    
Serum [bdsu]    
Level [qlco]    
Platelet Count [lbpr]    
Histologic [ftcn]    
Stage [ftcn]    
Hepatitis C virus [virs]    
Subtype [clas]    
Hepatitis C virus [virs]    
Concentrate [menp]    
baseline [bodm]    
Adjusted [ftcn]    
Length [qnco]    
Follow-up [fndg]    
Assess [hlca]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
month [tmco]    
Group [idcn]    
month [tmco]    
Control Group [grup]    
Multivariate Analysis [qnco]    
Show [inpr]    
interferon therapy [topp]    
Decrease [qnco]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Compare [acty]    
Control Group [grup]    
Old [tmco]    
Age [orga]    
Male [fndg]    
low platelet count [fndg]    
High [qlco]    
Histologic [ftcn]    
Stage [tmco]    
Independence [idcn]    
Factor [ftcn]    
Associated [qlco]    
development [phsf]    
Hepatocellular carcinoma [neop]    
Hazard Ratio [qnco]    
Rate [acty]    
development [phsf]    
Hepatocellular carcinoma [neop]    
sustain [ftcn]    
Transient [popg]    
Non [ftcn]    
Confidence Interval [qnco]    
Cell [cell]    
Follow-up [fndg]    
patient [podg]    
Group [idcn]    
DI [orgf]    
Liver disease [dsyn]    
Relate [orch]    
patient [podg]    
Control Group [grup]    
DI [orgf]    
Liver disease [dsyn]    
Relate [orch]    
sustain [ftcn]    
Transient [popg]    
Group [idcn]    
DI [orgf]    
Liver disease [dsyn]    
Relate [orch]    
Survival Rates, Cumulative [qnco]    
Control Group [grup]    
Identical [qlco]    
First [qnco]    
year [tmco]    
Following [tmco]    
Diagnosis [fndg]    
Cumulative Survival Rate [qnco]    
Control Group [grup]    
Result [ftcn]    
1+ [qnco]    
year [tmco]    
Survival Rate [qnco]    
Control Group [grup]    
97 [inpr]    
Similar [qlco]    
trend [tmco]    
Seen [qlco]    
Survival Analysis [resa]    
DI [orgf]    
Liver disease [dsyn]    
I- [inch]    
year [tmco]    
Survival Rate [qnco]    
Control Group [grup]    
studies [mnob]    
interferon therapy [topp]    
Lower [spco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
Show [inpr]    
sustain [ftcn]    
Normal [resa]    
patient [podg]    
Show [inpr]    
Transient [popg]    
Normal [resa]    
Serum [bdsu]    
Level [qlco]    
Complete [qlco]    
interferon therapy [topp]    
Survival Analyses [resa]    
Determinant [lbpr]    
cause [ftcn]    
Death [orgf]    
Suggest [idcn]    
interferon therapy [topp]    
Long-term [tmco]    
Survival [acty]    
Hepatitis C, Chronic [dsyn]    
patient [podg]    
Therapies [ftcn]    
Possibly [qlco]    
Decrease [qlco]    
Mortalities [qnco]    
Liver disease [dsyn]    
Relate [orch]    
[c] [qnco]    
LISS [lbpr]    
